Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.47 | 3.54 | 0.07 |
Stocks | 94.09 | 94.09 | 0.00 |
Other | 2.45 | 2.59 | 0.14 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.58 | 13.79 |
Price to Book | 2.55 | 2.07 |
Price to Sales | 1.64 | 1.31 |
Price to Cash Flow | 10.15 | 9.53 |
Dividend Yield | 2.78 | 3.09 |
5 Years Earnings Growth | 7.54 | 10.01 |
Name | Net % | Category Average |
---|---|---|
Industrials | 23.81 | 20.25 |
Consumer Cyclical | 16.54 | 14.07 |
Healthcare | 13.91 | 9.63 |
Financial Services | 12.79 | 17.38 |
Consumer Defensive | 9.52 | 11.81 |
Energy | 8.71 | 6.68 |
Communication Services | 7.46 | 7.13 |
Real Estate | 2.69 | 3.10 |
Basic Materials | 2.65 | 5.61 |
Technology | 1.28 | 7.25 |
Utilities | 0.65 | 3.71 |
Number of long holdings: 47
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.92 | 32.16 | +0.47% | |
Unilever | GB00B10RZP78 | 5.42 | 55.36 | -0.65% | |
Compass | GB00BD6K4575 | 4.32 | 2,791.00 | +1.05% | |
Rentokil | GB00B082RF11 | 3.84 | 398.80 | +1.01% | |
NatWest Group | GB00BM8PJY71 | 3.71 | 433.10 | -0.14% | |
GSK plc | GB00BN7SWP63 | 3.64 | 1,405.00 | +0.21% | |
HALEON | GB00BMX86B70 | 3.60 | 374.70 | -0.27% | |
Verisk | US92345Y1064 | 3.34 | 287.44 | -0.22% | |
AstraZeneca | GB0009895292 | 3.33 | 11,344.0 | +0.27% | |
Dunelm | GB00B1CKQ739 | 3.33 | 988.00 | +0.20% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Majedie UK Equity Class B Acc | 192.09M | 14.19 | 6.23 | 6.17 | ||
Majedie UK Focus Class X Accumulati | 6.62M | 14.63 | 2.60 | 5.48 | ||
Majedie UK Focus Class X Income | 3.76M | 14.63 | 2.60 | 5.49 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review